ABSTRACT
Idiopathic digital infarction (IDI), a rare subset of digital infarction, is characterized by ischemic changes in the absence of identifiable underlying etiology. We present the first documented case of IDI in a 47‐year‐old female with insignificant medical history. Clinical evaluation revealed bluish discoloration of the left lateral three fingers. Negative findings on autoimmune serologies, echocardiogram, and coagulation profiles excluded common causes, such as vasculitis, cardiac embolism, and hypercoagulable states. Imaging studies demonstrated ischemic changes in the left cerebellar hemisphere and proximal left subclavian artery, which supported the diagnosis of acute infarction. The patient was managed conservatively and was discharged. This case underscores the diagnostic complexities of IDI and highlights the importance of thorough evaluation and management.
Keywords: digital infarction, digital ischemia, hand, idiopathic
Summary.
This case emphasizes the importance of a comprehensive diagnostic approach for assessing patients with digital infarctions.
Physicians must exclude all identifiable etiologies before concluding idiopathic digital infarction.
1. Introduction
Diminished blood perfusion poses a significant threat to tissue viability, progressing from ischemia to eventual tissue death, commonly referred to as infarction. The underlying etiology of ischemia or infarction is diverse, ranging from vasoconstriction or blockage of the supplying vessels to manifestation of systemic diseases such as vasculitis. Digital ischemia results from inadequate blood supply to digital tissue, subsequently leading to digital infarction (DI). The presence of digital pain accompanied by pallor or cyanosis of the skin alarm of impending digital infarction [1]. Idiopathic digital infarction (IDI) is a rare manifestation within the spectrum of digital infarction. Raimbeau et al. estimated the prevalence of IDI is 11.7% [2].
The diagnostic approach for digital infarction commences with a thorough patient history, guiding subsequent investigations, including noninvasive imaging modalities such as Doppler ultrasound (US), angiography, and magnetic resonance angiography (MRA) [1, 3]. Additionally, autoimmune antibodies, such as ANA and ANCA, can provide valuable insights to support diagnosis [4]. However, the diagnosis of idiopathic digital infarction is a diagnosis of exclusion, which is established after other diagnoses have been ruled out.
Effective treatment of digital infarction stems from early diagnosis before tissue viability is lost. Treatment approaches for DI vary from lifestyle changes and avoidance of stressors to medical therapy, such as using vasodilators and vasoprotective drugs [1, 3, 4].
Here, we report the first case report of idiopathic digital infarction in a healthy female. We discussed the possible causes of ID. In this case, the diagnosis was unattainable even after a through examinations, and investigations, and therefore, it is worth reporting, to highlight this rare case, and to encourage future research to identify possible clinical scenarios and underlying causes. We also present a review of the literature over the past 5 years on the causes that might result in digital ischemia/infarction.
2. Case History and Examination
A 47‐year‐old female with no remarkable medical history was admitted via the ER complaining of bluish discoloration of her left lateral three fingers that started 3 months prior to admission (Figure 1). Moreover, she confirmed the absence of experiencing Raynaud's phenomenon. On the physical exam, the patient was stable with no remarkable signs of systemic diseases or cardiovascular diseases. Additionally, there was no oral or genital ulcers, and the patient denied the presence of arthralgia, and other full systemic examination from head to toe was not significant. Blood pressure was 125/90, and her other vitals were within normal range.
FIGURE 1.

Shows infraction of the lateral three fingers of the left hand. (A) shows the palmar aspect, involving the distal portions of the lateral three fingers, and (B) shows the dorsal aspect the left hand.
3. Differential Diagnosis and Investigations
Vasculitis was at the top of our differential diagnosis; therefore, we ordered ANA and ANCA tests to confirm the diagnosis, which were negative for both. Therefore, vasculitis was excluded, and we started looking for other underlying causes. Additionally, the patient tested negative for HBsAg and anti‐HCV antibodies. Laboratory tests showed elevated inflammatory markers (ESR = 100 mm/hour, normally ≤ 20 mm/hour) and were positive for CRP (2.77 mg/dL, normally ≤ 0.5 mg/dL) (Table 1). Moreover, complete blood count (CBC) results were within the normal range except for mild elevation in the platelet counts, and creatinine levels were also normal. Coagulation test like PT, PTT, and INR where within normal ranges, and serum levels of protein‐C and anti‐thrombin III were also within normal range. However, platelet counts were slightly elevated about 473,000/μL (normal range 150 to 450 thousand/μL). CTA revealed partial filling defects in the proximal part (near the origin) of the left subclavian artery (Figure 2). The patient reported several episodes of fainting. Brain CT showed subtle hypodensities in the left cerebellar hemisphere (Figure 3). There were neither intra‐ nor extracranial hemorrhages with a normal ventricular system. Brain magnetic resonance imaging (MRI) was used to investigate hypodensities observed on CT. Brain MRI showed an area of abnormal signal intensity with diffusion restriction only in the inferior medial portion of the left cerebellar hemisphere, representing acute ischemic infarction in the left posterior inferior cerebellar artery (PICA) territory without hemorrhagic transformation (Figure 4). On post‐contrast images, grossly preserved enhancements of the vertebral, basilar, and proximal left PICA were observed. There was neither a midline shift nor a mass effect, with no vasogenic edema, the ventricular system was within the normal size, and a partial empty sella was evident (Figure 5). A prominent perioptic subarachnoid space (Figure 6) correlated with signs of increased intracranial pressure (ICP). Normal enhancement of the dural sinuses with no stenosis in the dominant right transverse sinus or thrombosis was observed. An echocardiogram was used to detect what gave rise to the partial filling defect in the left subclavian artery, it revealed mild left ventricular hypertrophy, mitral valve regurgitation grade 1, and trace tricuspid valve regurgitation.
TABLE 1.
Laboratory findings.
| Value | Reference range | |
|---|---|---|
| ESR | 100 | ≤ 20 mm/hour |
| CRP | 2.77 | 0–0.5 mg/dL |
| AST | 13.0 | 42.0–54.5 (U/L |
| RBC | 3.89 | 4.2–5.3 × 106/μL |
| HB | 11.6 | 11.7–16 g/dL |
| PCV | 34.6 | 35%–47% |
| Platelet | 473,000/μL | 150–450,000/μL |
| Anti‐thrombin III | 103.5% | 80%–130% |
| Protein C | 127.4% | 70%–140% |
| Glucose | 6.17 | 4.2–6.4 mmol/L |
| Creatinine | 67 | 44–80 μmol/L |
| ANA | Negative | |
| ANCA | Negative | |
| Anti‐HCV | Negative | |
| HBsAg | Negative |
FIGURE 2.

Displays two images obtained through CTA. In images A and B, the arrow points to the partial filling defects are observed in the proximal portion of the left subclavian artery.
FIGURE 3.

Shows a brain CT scan. The arrow points to subtle hypodensities in the left cerebellar hemisphere. These hypodensities may indicate various underlying conditions such as ischemia, infarction, or other pathological changes.
FIGURE 4.

(A) Shows a T1 intensity MRI, and the arrow points hypointensity in the left cerebellar hemisphere, in the inferior medial portion. (B) shows diffusion restriction MRI, and the arrow points to the area of the diffusion restriction. These changes represent acute ischemic infarction in the left posterior inferior cerebellar artery (PICA) territory without hemorrhagic transformation.
FIGURE 5.

The arrows in both picture points to partial empty sella, (A) sagittal plane and (B) coronal plane. Partial empty sella may indicate various pathology, like elevated intracerebral pressure.
FIGURE 6.

Shows a brain MRI image revealing with the red arrow pointing to the prominent perioptic subarachnoid space. This area contain CSF, and an enlargement may indicate elevated intracerebral pressure.
4. Treatment
Initially, the patient was treated with anticoagulant (Enoxaparin 80 mg/0.8 mL as Sc injection two times per day) and antiplatelet (aspirin 100 mg orally 1 time per day) drugs, and the digital ischemia stabilized (Figure 1). However, amputation was not performed because the digital ischemia was dry and was not complicated by infection.
5. Follow‐Up
At the 1‐month follow‐up, the patient was well and did not complain of any symptoms, and resolution of the digital infarction was evident.
5.1. Literature Review
A literature review was conducted using the PubMed database, limiting the search to the past 5 years. The following search terms were used: ((“digital ischemia”) NOT (“myocardial” OR “stroke” OR “intestinal” OR “mesenteric” OR “rectal” OR “subtraction”)). This yielded 134 studies; after meticulous exclusion of irrelevant studies, 60 studies were identified as relevant. The scope of the included studies encompassed digital ischemia or infarction regardless of whether they were idiopathic (Table 2). Despite this meticulous search strategy, no case reports specifically addressing idiopathic digital ischemia have been published.
TABLE 2.
Characteristics of patients with digital infarction.
| Study ID | DOP | Age (years) | Gender | Fingers infarcted | The disease underlying the infarction | Outcome |
|---|---|---|---|---|---|---|
| Attal et al, (2018) [5] | 2018 | 83 | Female | Left hand | Ranibizumab | Auto‐amputation of left fifth distal phalange and complete healing of other fingers |
| Martins‐Rocha et al, (2020) [6] | 2018 | 14 months | Female | Right third and fourth | Post‐infectious | Complete resolution |
| Hari and Skeik, (2020) [7] | 2019 | 52 | Male | Bilateral second and right fourth | Behcet | Complete resolution |
| Kampoli et al, (2019) [8] | 2019 | 78 | Male | Right second–fifth, left third | Clear‐cell renal‐cell carcinoma ass paraneoplastic | Symptomatic improvement |
| Alzayer and Hasan, (2019) [9] | 2019 | 39 | Male | Left second and third | Hypereosinophilic vasculitis | Symptomatic improvement |
| Khaddour et al, (2019) [10] | 2019 | 68 | Female | Right first–fourth; left first second, third, and fifth | Immune checkpoint inhibitors | Progressed to dry gangrene |
| Zenati et al, (2020) [11] | 2019 | 47 | Male | Right second | Ipilimumab | Digital ulceration |
| Peña Arce et al, (2019) [12] | 2019 | 45 | Female | Bilateral second–fifth | HCV vasculitis | Dry gangrene in some fingers |
| Kurup and Simpson, (2019) [13] | 2019 | 43 | Male | All fingers | Sepsis | Complete resolution |
| Mülkoğlu and Genç, (2019) [14] | 2019 | 37 | Female | Right third–fifth | Hypothenar hammer syndrome | Complete resolution |
| Antonescu et al, (2019) [15] | 2019 | 47 | Female | All fingers | Fibromuscular dysplasia | Symptomatic improvement |
| St‐Pierre et al, (2019) [16] | 2019 | 56 | Male | Right third, fourth, fifth | Hypothenar hammer syndrome | Complete resolution |
| Schultz and Wolf, (2020) [17] | 2020 |
Case 1: 70 Case 2: 43 |
Case 1: Female Case 2: Male |
Case 1: Right 2nd‐4th Case 2: Right first and second |
Case 1: Covid‐19 Case 2: Covid‐19 |
Case 1: Ischemia remained stable until she died Case 2: Eschar formation |
| Serra‐García et al, (2021) [18] | 2020 | 48 | Female | Right second–fourth; left fifth | Covid‐19 | Symptomatic improvement |
| Cheemalavagu et al, (2020) [19] | 2020 | 50 | Female | Left second–fourth | Adalimumab‐induced antiphospholipid syndrome | Complete resolution |
| Aljahany et al, (2020) [20] | 2020 | 26 | Female | Right second | Epinephrine | Complete resolution |
| Kumar et al, (2020) [21] | 2020 | 45 | Female | Right first; left second | Brachial artery cannulation | Surgical amputation |
| Détriché et al, (2020) [22] | 2020 | 31 | Female | Left second–fifth | Arterial injection of crushed zolpidem | Surgical amputation of intermediate and distal phalanges |
| Imran et al, (2021) [23] | 2020 | 30 | Male | Right second | King cobra bite | Ray amputation |
| Ishii et al, (2020) [24] | 2020 | 61 | Female | Right third; left second | Hypereosinophilic syndrome | Complete resolution |
| Earl, (2020) [25] | 2020 | 46 | Female | Right second and third | Post transradial access | Surgical amputation |
| Martín Pedraz et al, (2022) [26] | 2021 | 11 | Male | Right fifth | Catastrophic antiphospholipid syndrome | Complete resolution |
| Shah et al, (2021) [27] | 2021 | 34 | Female | Right hand | Covid‐19 | Progressed to dry gangrene, the patient died before the scheduled amputation |
| Collado et al, (2021) [28] | 2021 | 48 | Female | Right second and third; left second | Antiphospholipid syndrome and breast cancer | Necrosis increased until she died |
| Jesani et al, (2021) [29] | 2021 | 57 | Female | All fingers | Norepinephrine | Progressed to gangrene |
| Acherjee et al, (2021) [30] | 2021 | 67 | Male | Right first | Covid‐19 | Symptomatic improvement |
| Vulasala et al, (2021) [31] | 2021 | 51 | Male | Right second; left second–fifth | Granulomatosis with polyangiitis causing Raynaud | Surgical amputation of three fingers |
| Jadhav et al, (2021) [32] | 2021 | 18 weeks (26 weeks preterm) | Male | Right second | Septicemia | Complete resolution |
| Schjødt et al, (2021) [33] | 2021 | 75 | Male | All fingers | Covid‐19 + systemic sclerosis | Symptomatic improvement |
| Ravi et al, (2021) [34] | 2021 | 45 | Female | Left second–fifth | Undifferentiated connective tissue disease | Auto‐amputation of involved fingers |
| Klanidhi et al, (2021) [35] | 2021 | 79 | Female | Right second and fourth; left third and fourth | Acral vascular syndrome secondary to lymphoma | Gangrene |
| Rajiah et al, (2021) [36] | 2021 | 32 | Male | Right first | Adrenaline | Complete resolution |
| AlRasbi et al, (2021) [37] | 2021 | 65 | Male | Right second–fourth | Paraneoplastic acral vascular syndrome | Resolution of all fingers except third became gangrenous |
| Swarup et al, (2021) [38] | 2021 | 58 | Male | Right second | Necrotizing granulomatous vasculitis | Surgical distal amputation |
| Potluri et al, (2021) [39] | 2021 | 56 | Female | All fingers | Chemotherapy‐induced raynaud | Symptomatic improvement |
| Hong et al, (2021) [40] | 2021 | 57 | Female | Right fifth | Epinephrine containing nerve block | Surgical amputation |
| Chen et al, (2021) [41] | 2021 | 52 | Female | Left second–fifth | Malignancy associated antiphospholipid syndrome | Surgical amputation |
| Kennedy et al, (2022) [42] | 2022 | 47 | Female | Left fourth and fifth | Post transradial access | Surgical amputation of distal phalanges |
| Huang et al, (2022) [43] | 2022 | Oxaliplatin | ||||
| McNamara and Greyson, (2022) [44] | 2022 | 72 | Female | Right fourth | Raynaud + lidocaine and epinephrine injection | Wound healed with persistent stiffness |
| Patel et al, (2022) [45] | 2022 | 41 | Male | Left all fingers | Thenar hammer syndrome | Symptomatic improvement |
| Fuchsberger et al, (2022) [46] | 2022 | 53 | Female | Left first–third | Covid‐19 | |
| Niitsuma et al, (2022) [47] | 2022 | 70 | Male | Right fifth | Blunt injury (hypothenar hammer syndrome) | Complete resolution |
| Estíbaliz et al, (2022) [48] | 2022 | 63 | Male | Right fourth | Hypothenar hammer syndrome | Complete resolution |
| Honan et al, (2022) [49] | 2022 | 39 | Female | Right second and third | Systemic sclerosis | Complete resolution |
| Akhlaghi Kalahroodi et al, (2022) [50] | 2022 | 45 | Male | Left second | ANCA vasculitis and antiphospholipid | Gangrene |
| Momen Majumder et al, (2022) [51] | 2022 | 32 | Male | All fingers | Non‐hodgkin lymphoma | Surgical amputation |
| Shoji et al, (2022) [52] | 2022 | 66 | Female | Left third | Systemic sclerosis | Complete resolution |
| Hidalgo Calleja et al, (2023) [53] | 2023 | 60 | Female | Right second–fifth | Graft versus host disease | Resolution for all fingers except third |
| Nayaz et al, (2023) [54] | 2023 | 42 | Female | Right first | Epinephrine | Complete resolution |
| Mateen et al, (2023) [55] | 2023 | 52 | Male | NR | Heparin induced thrombocytopenia | NR |
| Lee et al, (2023) [56] | 2023 | 38 | Female | Right third–fifth | Idiopathic radial artery occlusion | Symptomatic improvement |
| De Hous et al, (2023) [57] | 2023 | 46 | Female | Left fingers | Covid‐19 | Unknown |
| Wangtiraumnuay et al, (2023) [58] | 2023 | 19 months | Female | Left all fingers | Antiphospholipid + paraneoplastic + chemotherapy | Surgical amputation |
| Franco et al, (2023) [59] | 2023 | 65 | Female | All fingers | Systemic sclerosis + multiple myeloma | Surgical amputation |
| Dukan et al, (2023) [60] | 2023 | 36 | Male | Left second | Ruptured digital artery aneurysm | Complete resolution |
| Suwanto et al, (2023) [61] | 2023 | 69 | Male | Left first, third, and fourth | Dialysis access steal syndrome | Surgical amputation |
| Türkel et al, (2023) [62] | 2023 | 54 | Female | Left fifth | Gemcitabine | Surgical amputation of distal phalanx |
| Ibodeng et al, (2023) [63] | 2023 | 41 | Female | Left fourth and fifth | Hypothenar hammer syndrome | Complete resolution |
Abbreviations: DOP, date of publication; NR, not reported.
6. Discussion
Digital infarction/ischemia is a rare condition with an incidence of 2 per 100,000 persons per year [64, 65], including cardiac or arterial embolism, systemic autoimmune connective tissue disorders (e.g., systemic sclerosis), thromboangiitis obliterans, vasculitis, iatrogenic (drug‐induced, especially chemotherapy [66, 67], or due to operations such as cannulation [21]), paraneoplastic acral vascular syndrome [68], local thrombosis, traumatic injury, and hypothenar hammer syndrome [2]. According to the literature review conducted for this study for all case reports of DI in the last 5 years, an emerging cause is COVID‐19 infection, with the cause of the DI being identified as a hypercoagulable state [69].
The definitive diagnosis of DI is primarily based on the clinical presentation of pain associated with permanent blanching or cyanosis of the digits, along with desquamation and ulceration. In our case, the patient exhibited some elements of this clinical picture, complaining of pain and bluish discoloration without desquamation or ulceration. This presentation led to the diagnosis of DI. However, establishing a specific etiology for our patient proved challenging.
Common causes of DI, such as cardioembolic disease and small vessel vasculitis, were ruled out through an echocardiogram that showed no thrombi in the heart and negative serum levels of ANCA, ANA, HBsAg, and anti‐HCV. A hypercoagulable state was excluded based on a normal coagulation profile, and the patient's non‐smoking status and uneventful obstetric history further supported this exclusion. Slightly elevated platelet counts were considered insignificant as platelet counts are elevated in stressful states, and elevated CRP and ESR supported this conclusion. Additionally, there was no clear history of Raynaud's phenomenon and on examination, there was no digital ulceration which mainly occurs due to the vascular involvement in scleroderma which excludes systemic sclerosis or scleroderma [70]. Moreover, there was no trauma to the affected hand or a medical or surgical history that could predispose to the condition.
Furthermore, the patient's free medical history and not remarkable physical examination along normal vitals led us to exclude paraneoplastic acral vascular syndrome. Consequently, the DI was labeled as idiopathic, given the absence of a specific underlying cause in the patient's clinical presentation.
The patient's high ESR titer and positive CRP align with findings in most cases of idiopathic DI, as reported by Raimbeau et al., where the mean CRP value in the idiopathic group was 28.4 ± 36.9, ranking as the second‐highest mean after the iatrogenic group. Despite this, the discovery is nonspecific, and there may be an alternative underlying etiology.
The treatment regimen involving anticoagulant and antiplatelet drugs in our case proved effective, leading to the patient's discharge without the necessity for more aggressive management options, such as Botox [71], or digital sympathectomy. The latter procedure is associated with long‐term benefits for patients experiencing digital ischemia due to autoimmune conditions [72]. With such a presentation and the absence of predisposing conditions or any significant findings, we present an idiopathic case of digital infarction.
However, diagnosing IDI should be established following excluding other possible causes, absence of the diagnosis should not prevent prompt conservative management like anticoagulant and antiplatelet therapy can prevent further tissue damage and improve patient outcomes. Clinicians should consider IDI in the differential diagnosis of patients presenting with digital ischemia, especially when common causes have been excluded.
In conclusion, idiopathic digital infarction poses diagnostic challenges owing to its rarity and lack of identifiable underlying causes. We present the first case report of IDI in a 47‐year‐old female of the three left lateral fingers. Thorough evaluation, including autoimmune serologies, echocardiogram, and coagulation profiles, ruled out most common causes, such as vasculitis, cardiac embolism, and hypercoagulable states. Imaging studies confirmed acute infarction in the left cerebellar hemisphere and proximal left subclavian artery. Despite the absence of a definitive etiology, the patient responded well to conservative management, emphasizing the importance of early diagnosis and comprehensive evaluation in such cases.
Author Contributions
Jaber H. Jaradat: writing – original draft, writing – review and editing. Wadi Walid I: writing – original draft, writing – review and editing. Aram F. Obeidat: writing – original draft, writing – review and editing. Raghad Amro: writing – original draft, writing – review and editing. Abdulqadir J. Nashwan: writing – original draft, writing – review and editing.
Consent
Written informed consent was obtained from the patient to publish this report, in accordance with the journal's patient consent policy.
Conflicts of Interest
The authors declare no conflicts of interest.
Acknowledgments
Open Access funding provided by the Qatar National Library.
Funding: The authors received no specific funding for this work.
Data Availability Statement
The data presented in this study are available within the article.
References
- 1. McMahan Z. H. and Wigley F. M., “Raynaud's Phenomenon and Digital Ischemia: A Practical Approach to Risk Stratification, Diagnosis and Management,” International Journal of Clinical Rheumatology 5, no. 3 (2010): 355–370. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Raimbeau A., Pistorius M. A., Goueffic Y., et al., “Digital Ischaemia Aetiologies and Mid‐Term Follow‐Up: A Cohort Study of 323 Patients,” Medicine (Baltimore) 100, no. 20 (2021): e25659. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Herrick A. L., “The Pathogenesis, Diagnosis and Treatment of Raynaud Phenomenon,” Nature Reviews Rheumatology 8, no. 8 (2012): 469–479. [DOI] [PubMed] [Google Scholar]
- 4. Wigley F. M., “Clinical practice. Raynaud's Phenomenon,” New England Journal of Medicine 347, no. 13 (2002): 1001–1008. [DOI] [PubMed] [Google Scholar]
- 5. Attal R., Lazareth I., Angelopoulos G., and Priollet P., “Ranibizumab and Digital Ischemia,” Journal de Medecine Vasculaire 43, no. 1 (2018): 65–69. [DOI] [PubMed] [Google Scholar]
- 6. Martins‐Rocha T., Matias J. P., Vicente Ferreira M., Mota B., and Brito I., “Post‐Infectious Digital Ischemia Successfully Treated With Iloprost in a Child,” Reumatologia Clinica 16, no. 5 Pt 1 (2020): 364–365. [DOI] [PubMed] [Google Scholar]
- 7. Hari G. and Skeik N., “Digital Ischemia in Behcet's Disease: Case‐Based Review,” Rheumatology International 40, no. 1 (2020): 137–143. [DOI] [PubMed] [Google Scholar]
- 8. Kampoli K., Gardeli D., Mouktaroudi M., Fanouriakis A., Lazaris A. M., and Koumarianou A., “Paraneoplastic Digital Ischemia in Clear‐Cell Renal‐Cell Carcinoma: Report of a Case and Review of the Literature,” Urologia 86, no. 3 (2019): 156–160. [DOI] [PubMed] [Google Scholar]
- 9. Alzayer H. and Hasan M. A., “Hypereosinophilic Vasculitis: A Case Report,” Medicine (Baltimore) 98, no. 17 (2019): e15392. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Khaddour K., Singh V., and Shayuk M., “Acral Vascular Necrosis Associated With Immune‐Check Point Inhibitors: Case Report With Literature Review,” BMC Cancer 19, no. 1 (2019): 449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Zenati N., Charles J., Templier I., and Blaise S., “Digital Ischaemia With Fingertip Ulcers During Ipilimumab Therapy,” Annales de Dermatologie et de Vénéréologie 147, no. 3 (2020): 212–216. [DOI] [PubMed] [Google Scholar]
- 12. Pena Arce C., Ortego Centeno N., Sanchez Cano D., and Perez L. C., “Digital Ischaemia and HCV, a Vasculitis of Uncertain Aetiology,” BML Case Reports 12, no. 6 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Kurup V. and Simpson R. S., “Sepsis‐Induced Digital Ischaemia in a Professional Pianist, in the Absence of Vasopressors,” BML Case Reports 12, no. 10 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Mulkoglu C. and Genc H., “Ulnar Artery Thrombosis Presented With Unilateral Raynaud's Phenomenon Findings After Long‐Term Intensive Handicraft Activity: Hypothenar Hammer Syndrome,” Annals of Vascular Surgery 57, no. 275 (2019): e13–e15. [DOI] [PubMed] [Google Scholar]
- 15. Antonescu I., Knowles M., Wirtz E., and Pascarella L., “An Unusual Case of Bilateral Upper Extremity Ischemia Caused by Forearm Vessel Fibromuscular Dysplasia,” Annals of Vascular Surgery 56, no. 353 (2019): e7–e11. [DOI] [PubMed] [Google Scholar]
- 16. St‐Pierre F., Shepherd R. F., and Bartlett M. A., “Diagnosis of Hypothenar Hammer Syndrome in a Patient With Acute Ulnar Artery Occlusion,” BMJ Case Reports 12, no. 9 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Schultz K. and Wolf J. M., “Digital Ischemia in COVID‐19 Patients: Case Report,” Journal of Hand Surgery 45, no. 6 (2020): 518–522. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Serra‐Garcia L., Bosch‐Amate X., Alamon‐Reig F., et al., “Digital Ischemia Triggered by Coronavirus Disease 2019 in a Patient Under Cemiplimab Treatment,” International Journal of Dermatology 60, no. 1 (2021): e30–e32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Cheemalavagu S., McCoy S. S., and Knight J. S., “Digital Ischaemia Secondary to Adalimumab‐Induced Antiphospholipid Syndrome,” BML Case Reports 13, no. 2 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Aljahany M. S., Aleid D. K., and Aal Ibrahim A. M., “Reversal of Digital Ischemia With Phentolamine After Accidental Epinephrine Injection,” American Journal of Case Reports 21 (2020): e923877. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Kumar V., Salaria A. K., Kumar P., Dogra E., Singh G., and Aggarwal S., “Digital Ischemia Following Brachial Artery Cannulation in a Polytrauma Patient: A Case‐Based Discussion of Etiopathogenesis and Management,” Journal of Orthopaedic Case Reports 10, no. 2 (2020): 40–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Detriche G., Goudot G., Khider L., et al., “Acute Digital Ischemia After Arterial Injection of Crushed Zolpidem Tablets: Role of Microcrystalline Cellulose? A Case Report,” Frontiers in Pharmacology 11 (2020): 560382. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Imran R., Vanat Q., Hausien O., and Jose R., “King Cobra Bite—Can Early Decompression Prevent Digital Amputation?,” JPRAS Open 27 (2021): 12–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Ishii K., Mizuuchi T., Yamamoto Y., et al., “Development of Eosinophilic Temporal Arteritis and Digital Ischemia in a Patient With Hypereosinophilic Syndrome,” Internal Medicine 59, no. 10 (2020): 1323–1330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Earl T. J., “Acute Hand Ischemia and Digital Amputation After Transradial Coronary Intervention in a Patient With CREST Syndrome,” Texas Heart Institute Journal 47, no. 4 (2020): 319–321. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Martin Pedraz L., Galindo Zavala R., Nieto Vega F., Sanchez Bazan I., and Nunez C. E., “Digital Ischemia as the Initial Presentation of Catastrophic Antiphospholipid Syndrome,” Reumatologia Clinica 18, no. 1 (2022): 56–58. [DOI] [PubMed] [Google Scholar]
- 27. Shah H., Iyer A., Zaghlol R., and Raparla S., “Case Report: Multiple Strokes and Digital Ischemia in a Young COVID‐19 Patient,” American Journal of Tropical Medicine and Hygiene 104, no. 1 (2021): 60–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Collado M. V., Gandur M. N., Aguilar A., et al., “Triple Negative Breast Cancer, Repeated Abortions and Severe Digital Ischemia,” Medicina 81, no. 2 (2021): 289–292. [PubMed] [Google Scholar]
- 29. Jesani S., Elkattawy S., Noori M. A. M., et al., “Vasopressor‐Induced Digital Ischemia,” Cureus 13, no. 7 (2021): e16595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Acherjee T., Bastien B., Rodriguez‐Guerra M. A., Salman S., and Ali N., “Digital Ischemia as an Initial Presentation in a COVID‐19‐Positive Patient Without any Significant Respiratory Symptoms,” Cureus 13, no. 3 (2021): e14054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Vulasala S. S., Ahmed S., Onteddu N. K., Mannem M., and Mukkera S., “Raynaud's Secondary to Granulomatosis With Polyangiitis,” Cureus 13, no. 8 (2021): e17551. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Jadhav D. V., Mendonca D., Kotinatot S., Shankar S., and Mazmi M. A., “Nitroglycerin Patch Use in Digital Ischemia Secondary to Sepsis: A Case Report,” Pan African Medical Journal 38 (2021): 114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Schjodt M. S., Bech R., and Braae O. A., “Acral Necrosis in a COVID‐19‐Infected Man Treated With Botulinum Toxin Type A,” Case Reports in Dermatology 13, no. 3 (2021): 568–573. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Ravi P., Thabah M. M., Verghese R. J., Dineshbabu S., and Kadhiravan T., “Diagnosis of Undifferentiated Connective Tissue Disease in a Patient With Digital Gangrene and Positive Antinuclear Antibodies,” Cureus 13, no. 6 (2021): e15883. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Klanidhi K. B., Monian S. A., and Chakrawarty A., “Acral Vascular Syndrome Lennert Type T Cell Lymphoma‐a Case Report,” Journal of the Egyptian National Cancer Institute 33, no. 1 (2021): 8. [DOI] [PubMed] [Google Scholar]
- 36. Rajiah E., McKean A. R., and Bain C., “Accidental Adrenaline Auto‐Injector‐Induced Digital Ischaemia: A Proposed Treatment Algorithm,” BML Case Reports 14, no. 4 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. AlRasbi S., Al‐Badi A. H., and Al Alawi A. M., “Paraneoplastic Acral Vascular Syndrome: Case Presentation and Literature Review,” BML Case Reports 14, no. 1 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Swarup S., Kopel J., Thein K. Z., et al., “Sequential Complications of Hypercalcemia, Necrotizing Granulomatous Vasculitis, and Aplastic Anemia Occurring in One Patient With Angioimmunoblastic T‐Cell Lymphoma,” American Journal of the Medical Sciences 361, no. 3 (2021): 375–382. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Potluri T. K., Lee F. G., Song E., Wallace S. J., and Miller N., “Use of Botulinum Toxin A to Treat Chemotherapy‐Induced Raynaud's Phenomenon,” Cureus 13, no. 1 (2021): e12511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Hong I. S., Moontasri N. J., and Ratliff D. F., “Epinephrine‐Containing Digital Nerve Block: A Case of Digital Tip Necrosis Leading to Amputation in a Patient With no Known Vascular, Rheumatologic, or Smoking History,” Journal of Hand Surgery Global Online 3, no. 4 (2021): 215–217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Chen J. L., Yu X., Luo R., and Liu M., “Severe Digital Ischemia Coexists With Thrombocytopenia in Malignancy‐Associated Antiphospholipid Syndrome: A Case Report and Review of Literature,” World Journal of Clinical Cases 9, no. 36 (2021): 11457–11466. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Kennedy P., Klass D., and Chung J., “Non‐target Digital Ischemia in an Ulnar Artery Distribution Following Transradial Access: Case Report and Review of Best Practice Techniques,” Journal of Vascular Access 23, no. 4 (2022): 628–631. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Huang C., Storey L., and Chaudhary U., “Digital Ischaemia and Necrosis From Oxaliplatin,” BML Case Reports 15, no. 2 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. McNamara C. T. and Greyson M., “Digital Ischemia After Lidocaine With Epinephrine Injection in a Patient With Primary Raynaud's Phenomena,” Case Reports in Plastic Surgery & Hand Surgery 9, no. 1 (2022): 193–196. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Patel S. A., Munshi V., Bayrakdar K., and Guyer A., “A Case of Thenar Hammer Syndrome,” Cureus 14, no. 8 (2022): e28047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Fuchsberger S., Bloch‐Infanger C., and Mang G., “Livid Fingers After Respiratory Infection,” Praxis (1994) 111, no. 16 (2022): 947–950. [DOI] [PubMed] [Google Scholar]
- 47. Niitsuma G., Kawasaki K., and Inagaki K., “Digital Arterial Occlusion at the Metacarpophalangeal Joint With Hypothenar Hammer Syndrome‐Like Symptoms: A Case Report,” Journal of Orthopaedic Case Reports 12, no. 12 (2022): 1–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Estibaliz A. T., Eztizen L. S., Osman‐Alberto S. A., et al., “Bilateral Hypothenar Hammer Syndrome Case Presentation and Literature Review,” Case Reports in Vascular Medicine 2022 (2022): 2078772. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Honan K. A., Romero‐Karam L., Mayes M., and Arain S. A., “Total Percutaneous Revascularization of the Hand to Treat Refractory Digital Ischemia in Advanced Systemic Sclerosis,” JACC Case Report 4, no. 3 (2022): 161–166. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Akhlaghi Kalahroodi M., Loghman M., Ramezanpoor M., Shahriarirad R., and Rahmanian E., “Antineutrophil Cytoplasmic Antibody‐Associated Vasculitis in Presence of Positive Antiphospholipid Antibody: A Case Report,” Journal of Medical Case Reports 16, no. 1 (2022): 28. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Momen Majumder M. S., Ahmed S., Haque T., et al., “Digital Gangrene: An Unusual Manifestation of Non‐Hodgkin Lymphoma,” Case Reports in Vascular Medicine 2022 (2022): 8963753. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Shoji K., Zen K., Yanishi K., and Matoba S., “Successful Endovascular Therapy for Total Occlusion of the Distal Radial and Ulnar Artery with Palmar Artery Lesion in a Patient with Critical Hand Ischemia Associated with Systemic Sclerosis,” Vascular and Endovascular Surgery 56, no. 3 (2022): 340–343. [DOI] [PubMed] [Google Scholar]
- 53. Hidalgo Calleja C., Montilla Morales C. A., Sanchez Gonzalez M. D., et al., “Critical Digital Ischemia and Biliary Cholangitis Related to Graft Versus Host Disease: A Case Report and Systematic Literature Review,” Medicine (Baltimore) 102, no. 2 (2023): e32495. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Nayaz M., Mohamed A., and Nawaz A., “Accidental Digital Ischemia by an Epinephrine Autoinjector,” Cureus 15, no. 3 (2023): e36429. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Mateen S., Pontious J., Buckmaster M., and Hasenstein T., “Bilateral Digital Ischemia Secondary to Heparin‐Induced Thrombocytopenia With Subsequent Limb Salvage: A Case Study,” Journal of the American Podiatric Medical Association 113, no. 4 (2023). [DOI] [PubMed] [Google Scholar]
- 56. Lee N., Gehring M. B., and Washington K. M., “Distal Bypass to the Deep Palmar Arch for Treatment of a Unique Presentation of Digital Ischemia,” Plastic and Reconstructive Surgery. Global Open 11, no. 7 (2023): e5121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. De Hous N., Hollering P., Van Looveren R., Tran T., De Roover D., and Vercauteren S., “Symptomatic Arterial Thrombosis Associated With Novel Coronavirus Disease 2019 (COVID‐19): Report of Two Cases,” Acta Chirurgica Belgica 123, no. 1 (2023): 81–84. [DOI] [PubMed] [Google Scholar]
- 58. Wangtiraumnuay N., Surakrattanaskul S., and Wangkittikul C., “Digital Gangrene and Antiphospholipid Syndrome in a Retinoblastoma Patient With Chromosome 13q Deletion: A Case Report,” Case Reports in Oncology 16, no. 1 (2023): 287–293. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Franco A. S., Polho G. B., Luppino Assad A. P., Miossi R., and Sampaio‐Barros P. D., “Critical Digital Ischaemia in Systemic Sclerosis Exacerbated by Multiple Myeloma: A Case Report,” Journal of Scleroderma and Related Disorders 8, no. 3 (2023): NP9–NP13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Dukan R., Lacroix M., Bertin E., Reverdito G., Fitoussi F., and Binder A. C., “Acute Digit Ischemia due to a Ruptured Digital Collateral Artery Aneurysm in a Patient of Hemophilia: A Case Report,” Journal of Orthopaedic Case Reports 13, no. 11 (2023): 70–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Suwanto D., Dewi I. P., Wardhani L. F. K., Noor Y. A., and Nugroho J., “Recognizing Dialysis Access Steal Syndrome With Central Vein Stenosis as Arteriovenous Fistula Complication: A Case Report,” International Journal of Surgery Case Reports 102 (2023): 107824. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Turkel A., Ozdemir M., Kurtulus A., and Dogan M., “Gemcitabine‐Associated Digital Necrosis in Metastatic Breast Cancer,” Journal of Oncology Pharmacy Practice 29, no. 7 (2023): 1770–1775. [DOI] [PubMed] [Google Scholar]
- 63. Ibodeng G. O., Olagunju O., Chukwurah Q., and Broadwell M., “Hypothenar Hammer Syndrome Presenting as Critical Limb Ischemia in a 41‐Year‐Old Caucasian Female; A Case Report,” Journal of Community Hospital Internal Medicine Perspectives 13, no. 5 (2023): 105–106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Carpentier P. H., Guilmot J. L., Hatron P. Y., et al., “Digital Ischemia, Digital Necrosis,” Journal des Maladies Vasculaires 30, no. 4 Pt 3 (2005): 29–37. [PubMed] [Google Scholar]
- 65. Pentti J., Salenius J. P., Kuukasjarvi P., and Tarkka M., “Outcome of Surgical Treatment in Acute Upper Limb Ischaemia,” Annales Chirurgiae et Gynaecologiae 84, no. 1 (1995): 25–28. [PubMed] [Google Scholar]
- 66. Cacoub P., De Lacroix I., Tazi Z., Piette J. C., and Godeau P., “Drug‐Induced Iatrogenic Arterial Diseases,” La Revue de Médecine Interne 16, no. 11 (1995): 827–832. [DOI] [PubMed] [Google Scholar]
- 67. Schapira D., Nahir A. M., and Hadad N., “Interferon‐Induced Raynaud's Syndrome,” Seminars in Arthritis and Rheumatism 32, no. 3 (2002): 157–162. [DOI] [PubMed] [Google Scholar]
- 68. Le Besnerais M., Miranda S., Cailleux N., et al., “Digital Ischemia Associated With Cancer: Results From a Cohort Study,” Medicine (Baltimore) 93, no. 10 (2014): e47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Putko R. M., Bedrin M. D., Clark D. M., Piscoya A. S., Dunn J. C., and Nesti L. J., “SARS‐CoV‐2 and Limb Ischemia: A Systematic Review,” Journal of Clinical Orthopaedics and Trauma 12, no. 1 (2021): 194–199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Ferri C., Valentini G., Cozzi F., et al., “Systemic Sclerosis: Demographic, Clinical, and Serologic Features and Survival in 1,012 Italian Patients,” Medicine (Baltimore) 81, no. 2 (2002): 139–153. [DOI] [PubMed] [Google Scholar]
- 71. Neumeister M. W., Chambers C. B., and Herron M. S., “Botox Therapy for Ischemic Digits,” Journal of Vascular Surgery 51, no. 2 (2010): 522. [DOI] [PubMed] [Google Scholar]
- 72. Kotsis S. V. and Chung K. C., “A Systematic Review of the Outcomes of Digital Sympathectomy for Treatment of Chronic Digital Ischemia,” Journal of Rheumatology 30, no. 8 (2003): 1788–1792. [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data presented in this study are available within the article.
